Methylene Blue for Vasopressor-Resistant Vasoplegia Syndrome During Liver Transplantation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 3, 2010, Pages 463-466

  Fischer, Gregory W ^a   Bengtsson, Ylva ^a   Scarola, Suzanne ^a   Cohen, Edmond ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

liver transplantation; methylene blue; vasoplegic syndrome

Indexed keywords

ADRENALIN; BICARBONATE; CALCIUM CHLORIDE; ETOMIDATE; FENTANYL; METHYLENE BLUE; NORADRENALIN; VASOPRESSIN; VECURONIUM;

ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; ASCITES; CASE REPORT; ESOPHAGUS VARICES BLEEDING; GENERAL ANESTHESIA; GRAFT OCCLUSION; HEPATORENAL SYNDROME; HUMAN; HYPOTENSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; METABOLIC ACIDOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY ACIDOSIS; SURGICAL INFECTION; THERAPY RESISTANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR DISEASE; VASOPLEGIA SYNDROME;

BLOOD PRESSURE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEPATITIS, AUTOIMMUNE; HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; METHYLENE BLUE; MIDDLE AGED; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASOPLEGIA;

EID: 77952585421     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.07.015     Document Type: Article

References (21)

1. Preiser J.C., Lejeune P., Roman A., et al. Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23 (1995) 259-264
2. Palmer R.M.J. The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis. Arch Surg 128 (1993) 396-401
3. Mayer B., Brunner F., and Schnidt K. Novel actions of methylene blue. Eur Heart J 14 (1994) 22-26
4. Myles P.S., Leong C.K., and Currey J. Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 5 (1997) 571-574
5. Mekontso-Dessap A., Houël R., Soustelle C., et al. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71 (2001) 1428-1432
6. Argenziano M., Chen J.M., Choudhri A.F., et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998) 973-980
7. Shanmugam G. Vasoplegic syndrome-The role of methylene blue. Eur J Cardiothorac Surg 28 (2005) 705-710
8. Carrel T., Englberger L., Mohacsi P., et al. Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance. J Card Surg 15 (2000) 347-353
9. Koelzow H., Gedney J.A., Baumann J., et al. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 94 (2002) 824-829
10. Hori N., Okanoue T., Mori T., et al. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol 23 (1996) 30-35
11. Schneider F., Lutun P., Boudjema K., et al. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 19 (1994) 38-44
12. Gomes W.J., Carvalho A.C., Palma J.H., et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino) 39 (1998) 619-623
13. Williams J.W., Vera S., Peters T.G., et al. Cholestatic jaundice after hepatic transplantation: A nonimmunologically mediated event. Am J Surg 151 (1986) 65-70
14. Leyh R.G., Kofidis T., Strüber M., et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?. J Thorac Cardiovasc Surg 125 (2003) 1426-1431
15. Levin R.L., Degrange M.A., Bruno G.F., et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77 (2004) 496-499
16. Maslow A.D., Stearns G., Butala P., et al. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 103 (2006) 2-8
17. Kofidis T., Strüber M., Wilhelmi M., et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg 122 (2001) 823-824
18. Grayling M., and Deakin C.D. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 125 (2003) 426-427
19. Kessler M.R. Spurious pulse oximeter desaturation with methylene blue injection. Anesthesiology 65 (1986) 435-436
20. Sinex J.E. Pulse oximetry: Principles and limitations. Am J Emerg Med 17 (1999) 59-67
21. Mittnacht A.J., Fischer G.W., and Reich D.L. Methylene blue administration is associated with decreased cerebral oximetry values. Anesth Analg 105 (2007) 549-550